✉ Email this page to a colleague
« Back to Dashboard
Ademetionine is an investigational drug.
There have been 7 clinical trials for Ademetionine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 30th 2020.
The most common disease conditions in clinical trials are Chemical and Drug Induced Liver Injury, Chemical and Drug Induced Liver Injury, Chronic, and Hepatitis B. The leading clinical trial sponsors are Beijing 302 Hospital, MSI Methylation Sciences, Inc., and Zhejiang Hisun Pharmaceutical Co. Ltd.
There are six hundred and eighty-seven US patents protecting this investigational drug and ten international patents.
Recent Clinical Trials for Ademetionine
|Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial||Li Yang||Phase 4|
|36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI||Beijing 302 Hospital||Phase 1/Phase 2|
|Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI||Beijing 302 Hospital||Phase 1/Phase 2|
Top disease conditions for Ademetionine
Top clinical trial sponsors for Ademetionine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Ademetionine||See Plans and Pricing||Method and culture medium for improving pluripotent stem cell differentiation inducing efficiency||NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (Kumamoto, JP)||See Plans and Pricing|
|Ademetionine||See Plans and Pricing||Devices and methods for continuous analyte monitoring||DexCom, Inc. (San Diego, CA)||See Plans and Pricing|
|Ademetionine||See Plans and Pricing||Advanced analyte sensor calibration and error detection||DexCom, Inc. (San Diego, CA)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Ademetionine||European Patent Office||EP2644694||2030-10-28||See Plans and Pricing|
|Ademetionine||Japan||JP5938726||2030-10-28||See Plans and Pricing|
|Ademetionine||Japan||JPWO2012056997||2030-10-28||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|